Seelos Therapeutics, Inc.
SEELQ
$0.0005
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 164.19% | 51.15% | -151.94% | 135.59% | -119.61% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 7.14% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.33% | -52.97% | 92.77% | -212.88% | 248.82% |
| Change in Net Operating Assets | 185.75% | -91.11% | -12.67% | 47.87% | 255.60% |
| Cash from Operations | 79.06% | -142.91% | 66.76% | 2.63% | 42.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 85.92% | 39.00% | -14.03% | 18.30% | -79.78% |
| Issuance of Common Stock | -73.39% | -22.18% | 2.24% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -65.81% | -6.59% | -6.71% | 207.70% | -126.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.70% | -700.00% | 112.64% | 60.33% | -457.39% |